Y Kadotani

449 total citations
35 papers, 345 citations indexed

About

Y Kadotani is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, Y Kadotani has authored 35 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Transplantation, 12 papers in Surgery and 8 papers in Nephrology. Recurrent topics in Y Kadotani's work include Renal Transplantation Outcomes and Treatments (17 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Organ Donation and Transplantation (5 papers). Y Kadotani is often cited by papers focused on Renal Transplantation Outcomes and Treatments (17 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Organ Donation and Transplantation (5 papers). Y Kadotani collaborates with scholars based in Japan, United States and Mexico. Y Kadotani's co-authors include Norio Yoshimura, Masahiko Okamoto, Kiyokazu Akioka, Hidetaka Ushigome, Atsushi Higuchi, Rikio Yoshimura, Satoshi Kaihara, Yoshihiro Ohmori, Shuji Nobori and Yoshihiro Wakabayashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Transplantation.

In The Last Decade

Y Kadotani

35 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Kadotani Japan 10 114 103 75 63 60 35 345
Takeshi Fujita Japan 12 68 0.6× 74 0.7× 65 0.9× 86 1.4× 56 0.9× 47 421
Theodoros Kassimatis Greece 13 78 0.7× 182 1.8× 135 1.8× 64 1.0× 64 1.1× 29 445
J. Strehlau Germany 14 61 0.5× 171 1.7× 295 3.9× 120 1.9× 98 1.6× 28 565
Delphine Morel France 11 57 0.5× 97 0.9× 97 1.3× 114 1.8× 20 0.3× 18 368
Xiang He China 10 54 0.5× 93 0.9× 184 2.5× 65 1.0× 43 0.7× 19 390
H. J. Schlitt Germany 12 114 1.0× 134 1.3× 63 0.8× 36 0.6× 30 0.5× 37 374
Olga Bessmertny United States 10 87 0.8× 28 0.3× 37 0.5× 14 0.2× 41 0.7× 17 364
Katy Lambert United States 7 56 0.5× 75 0.7× 39 0.5× 26 0.4× 152 2.5× 9 545
Javier Lendoire Argentina 14 101 0.9× 275 2.7× 28 0.4× 14 0.2× 20 0.3× 29 499
Bogdan Obrișcă Romania 12 68 0.6× 60 0.6× 66 0.9× 208 3.3× 18 0.3× 52 409

Countries citing papers authored by Y Kadotani

Since Specialization
Citations

This map shows the geographic impact of Y Kadotani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Kadotani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Kadotani more than expected).

Fields of papers citing papers by Y Kadotani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Kadotani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Kadotani. The network helps show where Y Kadotani may publish in the future.

Co-authorship network of co-authors of Y Kadotani

This figure shows the co-authorship network connecting the top 25 collaborators of Y Kadotani. A scholar is included among the top collaborators of Y Kadotani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Kadotani. Y Kadotani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakano, Katsunori, et al.. (2021). Mixed neuroendocrine–non-neuroendocrine neoplasms of the gallbladder: a case report. SHILAP Revista de lepidopterología. 7(1). 70–70. 3 indexed citations
2.
Nakatsukasa, Katsuhiko, Hiroshi Koyama, Naruhiko Mizuta, et al.. (2016). Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer. Breast Cancer. 24(1). 63–68. 33 indexed citations
3.
Kadotani, Y, et al.. (2009). Giant cell arteritis of the breast: a case report with a review of literatures. Breast Cancer. 17(3). 225–232. 13 indexed citations
4.
Kaihara, Satoshi, Masahiko Okamoto, Atsushi Higuchi, et al.. (2005). Improved Graft Survival in ABO-Incompatible Living Donor Kidney Transplantation. Transplantation Proceedings. 37(4). 1804–1805. 7 indexed citations
5.
Okamoto, Masahiko, Yoshihiro Wakabayashi, Atsushi Higuchi, et al.. (2005). Therapeutic Drug Monitoring of Mycophenolic Acid in Renal Transplant Recipients. Transplantation Proceedings. 37(2). 859–860. 21 indexed citations
6.
Okamoto, Masashi, Y Kadotani, Atsushi Higuchi, et al.. (2004). Recurrence of focal glomerulosclerosis in post–renal transplant recipients: Report of two cases. Transplantation Proceedings. 36(7). 2167–2168. 2 indexed citations
7.
Okamoto, Masahiko, Yoshihiro Omori, Shuji Nobori, et al.. (2004). An autopsy case of bacterial septic shock 12 years following ABO‐incompatible renal transplantation. Clinical Transplantation. 18(s11). 44–49. 6 indexed citations
8.
Kadotani, Y, et al.. (2003). アンチセンスTissue factor(TF)でのラット腎虚血再潅流障害の制御. 21(4). 163. 1 indexed citations
9.
Okamoto, Masahiko, et al.. (2003). Pediatric living-related renal transplantation under tacrolimus as the primary immunosuppressive agent. Transplantation Proceedings. 35(1). 165–166. 1 indexed citations
10.
Matsuyama, Masahide, Rikio Yoshimura, Kiyokazu Akioka, et al.. (2003). Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury. Transplantation. 76(5). 786–791. 45 indexed citations
11.
Okamoto, Masashi, et al.. (2003). Hypertrophic cardiomyopathy in a renal transplant recipient: a case report. Transplantation Proceedings. 35(1). 269–270. 2 indexed citations
12.
Okamoto, Masahiko, Shuji Nobori, Atsushi Higuchi, et al.. (2003). Clinicopathological evaluation of renal allografts of four patients by 20‐year protocol biopsies. Clinical Transplantation. 17(s10). 20–24. 2 indexed citations
13.
Ushigome, Hidetaka, Masahiko Okamoto, Kiyokazu Akioka, et al.. (2003). Pulmonary Embolism in a Living-Related Kidney Transplantation Donor. Surgery Today. 33(5). 399–402. 1 indexed citations
14.
Okamoto, Masahiko, et al.. (2003). Abdominal pain is a critical complication of mycophenolate mofetil in renal transplant recipients. Transplantation Proceedings. 35(1). 300–301. 4 indexed citations
15.
Kadotani, Y, et al.. (2002). Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. Transplantation Proceedings. 34(5). 1503. 2 indexed citations
16.
Matsuyama, Masahide, Masahiko Okamoto, Y Kadotani, et al.. (2002). The role of tissue factor in renal ischemic reperfusion injury by antisense oligodeoxynucleotide. Transplantation Proceedings. 34(5). 1475–1476. 4 indexed citations
17.
Ushigome, Hidetaka, Hajime Sano, Masahiko Okamoto, et al.. (2002). The Role of Tissue Factor in Renal Ischemic Reperfusion Injury of the Rat. Journal of Surgical Research. 102(2). 102–109. 23 indexed citations
18.
Nakamura, Kenji, Y Kadotani, Hidetaka Ushigome, et al.. (2002). Antisense oligonucleotide for tissue factor inhibits hepatic ischemic reperfusion injury. Biochemical and Biophysical Research Communications. 297(3). 433–441. 13 indexed citations
19.
Okamoto, Masahiko, et al.. (2002). Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single japanese center. Transplantation Proceedings. 34(5). 1666–1667. 1 indexed citations
20.
Nakamura, Kenji, Masahiko Okamoto, Masahide Matsuyama, et al.. (2001). Effect of antisense oligonucleotides for tissue factor on hepatic ischemia-reperfusion injury in the rat. Transplantation Proceedings. 33(7-8). 3707–3708. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026